On Friday, the United States approved the Pfizer Covid vaccine for children ages 5 to 11, setting the stage for early immunization for 28 million young Americans.
The conclusion arrived after an old medical commission recommended that the government approve the vaccine this week, saying the known benefits outweigh the risks of side effects.
This week, Pfizer and its partner BioNTech announced that the US government has purchased an additional 50 million cans to protect children, including those under the age of five. The safety of the vaccine has also been tested in over 3,000 children, and this study found no serious side effects.
Severe covid is in children is less common than in adults, but not in loved ones. More than 5,000 paediatrics cases of the juvenile multisystem inflammatory syndrome (MIS-C), a rare but very serious complication of post-viral illness, have been reported, including 46 deaths.
In the most severely affected groups, such as adolescent boys and young adults, after the second dose of mRNA vaccine, the effects usually appear at a rate of one in a million.
Most cases are fully resolved. Epidemiologists believe that vaccinating this group will not only protect the children’s health but also help end school holidays and other activities.
Instead, vaccination decisions should be based on factors such as the child’s risk factors and should be made by the family. Almost 58% of the total population is currently inoculated.